These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10051622)

  • 41. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.
    Cheng G; Ye ZS; Baltimore D
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8152-5. PubMed ID: 8058772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families.
    Guo S; Wahl MI; Witte ON
    Int Immunol; 2006 Jan; 18(1):79-87. PubMed ID: 16291652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.
    Vassilev A; Ozer Z; Navara C; Mahajan S; Uckun FM
    J Biol Chem; 1999 Jan; 274(3):1646-56. PubMed ID: 9880544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.
    Brunner C; Avots A; Kreth HW; Serfling E; Schuster V
    Immunobiology; 2002 Oct; 206(4):432-40. PubMed ID: 12437073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced formation of phosphatidic acid upon B-cell receptor triggering of mouse B-lymphocytes lacking Bruton's tyrosine kinase.
    Forssell J; Nilsson A; Sideras P
    Scand J Immunol; 2000 Jul; 52(1):30-8. PubMed ID: 10886781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
    Khan WN
    Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.
    Joseph RE; Kleino I; Wales TE; Xie Q; Fulton DB; Engen JR; Berg LJ; Andreotti AH
    Sci Signal; 2013 Aug; 6(290):ra76. PubMed ID: 23982207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling.
    Watanabe D; Hashimoto S; Ishiai M; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
    J Biol Chem; 2001 Oct; 276(42):38595-601. PubMed ID: 11507089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation.
    Bewarder N; Weinrich V; Budde P; Hartmann D; Flaswinkel H; Reth M; Frey J
    Mol Cell Biol; 1996 Sep; 16(9):4735-43. PubMed ID: 8756631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bruton's tyrosine kinase (Btk) associates with protein kinase C mu.
    Johannes FJ; Hausser A; Storz P; Truckenmüller L; Link G; Kawakami T; Pfizenmaier K
    FEBS Lett; 1999 Nov; 461(1-2):68-72. PubMed ID: 10561498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of monoclonal antibodies to Bruton's tyrosine kinase.
    Stewart DM; Kurman CC; Nelson DL
    Hybridoma; 1995 Jun; 14(3):243-6. PubMed ID: 7590786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
    Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
    Front Immunol; 2019; 10():95. PubMed ID: 30761150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
    J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.
    Kersseboom R; Ta VB; Zijlstra AJ; Middendorp S; Jumaa H; van Loo PF; Hendriks RW
    J Immunol; 2006 Apr; 176(8):4543-52. PubMed ID: 16585544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
    Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
    Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases.
    Schlaepfer DD; Hunter T
    Mol Cell Biol; 1996 Oct; 16(10):5623-33. PubMed ID: 8816475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.
    Calalb MB; Polte TR; Hanks SK
    Mol Cell Biol; 1995 Feb; 15(2):954-63. PubMed ID: 7529876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.